136 related articles for article (PubMed ID: 36341566)
1. The T Cell Receptor Repertoire Diversity Following Hematopoietic Stem Cell Transplantation.
Zamani F; Mirfakhraie R; Safaee Nodehi SR; Mollaei-Kandelous Y; Jafari H; Farahmand M; Rezaei F; Teymoori-Rad M; Movafagh A
Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):584-593. PubMed ID: 36341566
[TBL] [Abstract][Full Text] [Related]
2. Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.
Buhler S; Bettens F; Dantin C; Ferrari-Lacraz S; Ansari M; Mamez AC; Masouridi-Levrat S; Chalandon Y; Villard J
Leukemia; 2020 May; 34(5):1422-1432. PubMed ID: 31772297
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
Hentschke P; Omazic B; Mattsson J; Näsman-Björk I; Lundkvist I; Gigliotti D; Barkholt L; Ringdén O; Remberger M
Scand J Immunol; 2005 Mar; 61(3):285-94. PubMed ID: 15787747
[TBL] [Abstract][Full Text] [Related]
4. Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation.
Gkazi AS; Margetts BK; Attenborough T; Mhaldien L; Standing JF; Oakes T; Heather JM; Booth J; Pasquet M; Chiesa R; Veys P; Klein N; Chain B; Callard R; Adams SP
Front Immunol; 2018; 9():2547. PubMed ID: 30455696
[TBL] [Abstract][Full Text] [Related]
5. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.
Shah O; Tamaresis JS; Kenyon LJ; Xu L; Zheng P; Gupta P; Rangarajan K; Lee S; Spellman S; Nikiforow S; Zehnder J; Meyer EH
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1050-1070. PubMed ID: 32081787
[TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.
Friedman TM; Varadi G; Hopely DD; Filicko J; Wagner J; Ferber A; Martinez J; Brunner J; Grosso D; McGuire L; Korngold R; Flomenberg N
Biol Blood Marrow Transplant; 2001; 7(12):656-64. PubMed ID: 11787528
[TBL] [Abstract][Full Text] [Related]
8. Thymic Activity and T Cell Repertoire Recovery after Autologous Hematopoietic Stem Cell Transplantation Preceded by Myeloablative Radiotherapy or Chemotherapy.
Głowala-Kosińska M; Chwieduk A; Smagur A; Fidyk W; Najda J; Mitrus I; Giebel S
Biol Blood Marrow Transplant; 2016 May; 22(5):834-42. PubMed ID: 26797400
[TBL] [Abstract][Full Text] [Related]
9. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.
Memon SA; Sportès C; Flomerfelt FA; Gress RE; Hakim FT
J Immunol Methods; 2012 Jan; 375(1-2):84-92. PubMed ID: 21986106
[TBL] [Abstract][Full Text] [Related]
13. Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Georges GE; Storb R
Int J Hematol; 2003 Jan; 77(1):3-14. PubMed ID: 12568294
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantation.
Li Y; Xu L
Stem Cell Investig; 2015; 2():17. PubMed ID: 27358885
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].
Yuan X; Sun ZM; Liu HL; Geng LQ; Wang ZY; Tong J; Yao W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):614-7. PubMed ID: 18549640
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade.
Sutherland JS; Spyroglou L; Muirhead JL; Heng TS; Prieto-Hinojosa A; Prince HM; Chidgey AP; Schwarer AP; Boyd RL
Clin Cancer Res; 2008 Feb; 14(4):1138-49. PubMed ID: 18281548
[TBL] [Abstract][Full Text] [Related]
18. Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution.
Delmonte OM; Castagnoli R; Yu J; Dvorak CC; Cowan MJ; Dávila Saldaña BJ; De Ravin SS; Mamcarz E; Chang CK; Daley SR; Griffith LM; Notarangelo LD; Puck JM
J Allergy Clin Immunol; 2022 Mar; 149(3):1113-1119. PubMed ID: 34384841
[TBL] [Abstract][Full Text] [Related]
19. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.
Atilla E; Ataca Atilla P; Demirer T
Balkan Med J; 2017 Jan; 34(1):1-9. PubMed ID: 28251017
[TBL] [Abstract][Full Text] [Related]
20. T cell replete-haploidentical second hematopoietic stem cell transplantation for primary graft failure in pediatric patients with hematologic malignancies.
Mochizuki K; Sano H; Akaihata M; Kobayashi S; Waragai T; Ohara Y; Takahashi N; Ito M; Ikeda K; Ohto H; Kikuta A
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28845543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
